 |
|
|
| |
Real-World Effectiveness of Sofosbuvir and Ledipasvir/Sofosbuvir Based Regimens in Hepatitis C Virus Genotype 3 Infection Within National Hepatitis C Elimination Program in the Country of Georgia
|
| |
| |
Reported by Jules Levin
AASLD Liver Meeting Oct 20-24 2017, Washington DC
Tengiz Tsertsvadze,1,2 Nikoloz Chkhartishvili,1 Akaki Abutidze,1 Lali Sharvadze,2,3 Vakhtang Kerashvili,1 George Kamkamidze,4 Mamuka Zakalashvili,5 Lia Gvinjilia,6 Muazzam Nasrullah,7 Amiran Gamkrelidze,8 Valeri Kvaratskhelia,9 Stefan Zeuzem, 10 Sanjeev Arora,11 Karla Thornton, 11 Nezam Afdhal,12 Francisco Averhoff7
Infectious Diseases, AIDS and Clinical Immunology Research Center 1Infectious Diseases, AIDS and Clinical Immunology Research Center, Tbilisi, Georgia; 2Ivane Javakhishvili Tbilisi State University, Tbilisi, Georgia; 3Hepatology Clinic Hepa, Tbilisi, Georgia; 4NeoLab, Tbilisi, Georgia; 5Mrcheveli, Tbilisi, Georgia; 6CDC Foundation, Tbilisi, Georgia; 7Division of Viral Hepatitis, National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention, CDC, Atlanta, GA, USA; 8National Center for Disease Control and Public Health, Tbilisi, Georgia; 9Ministry of Labour, Health and Social Affairs of Georgia, Tbilisi, Georgia; 10 Goethe University Hospital, Frankfurt, Germany; 11 University of New Mexico, Albuquerque, NM, USA; 12Harvard Medical School, Boston, MA, USA
|
| |
|
|
|
|
|
